MSB 3.83% $1.26 mesoblast limited

MSB 2023 - awaiting for Ryoncil approval, page-8

  1. 2,744 Posts.
    lightbulb Created with Sketch. 1843
    New Year musings

    Next week is 90 days since the new potency assay data was sent to CBER.
    I’m making this up- but 90 days turnaround time for feedback is a distinct possibility.
    I’m being presumptuous and presupposing that the BLA resubmission is ready to go - however we await feedback on the IND file submission which was marked as price sensitive.

    Yup - I reckon we are on the CBER clock - a new dawn is about to occur in the scientific medical community- they are also dotting their eyes and crossing their t’s.

    I had a look at the Clbp trial follow up - it was 36 months so no 4 year update coming the week after.



    Have a great 2023

    If you can’t handle the wait- sell


    Will be happy to take them off your hands


    Please listen closely to Sorepocket , Sector and Whytee
    they are brilliant - original material - very positive chaps


    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.26
Change
-0.050(3.83%)
Mkt cap ! $1.432B
Open High Low Value Volume
$1.27 $1.30 $1.17 $18.26M 14.78M

Buyers (Bids)

No. Vol. Price($)
15 120701 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.26 97998 15
View Market Depth
Last trade - 15.05pm 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.